Regulatory agencies' expectations for biotherapeutic approval are becoming more stringent with regard to product characterization, where minor species as low as 0.1% of a given profile are typically identified. The mission of this manuscript is to demonstrate a multi-method approach toward de novo glycan characterization and quantitation, including minor species at or approaching the 0.1% benchmark. Recently, unexpected isomers of the Man 5 GlcNAc 2 (M 5 ) were reported (Prien JM, Ashline DJ, Lapadula AJ, Zhang H, Reinhold VN. 2009. The high mannose glycans from bovine ribonuclease B isomer characterization by ion trap mass spectrometry (MS). J Am Soc Mass Spectrom. 20:539-556). In the current study, quantitative analysis of these isomers found in commercial M 5 standard demonstrated that they are in low abundance (<1% of the total) and therefore an exemplary "litmus test" for minor species characterization. A simple workflow devised around three core well-established analytical procedures: (1) fluorescence derivatization; (2) online rapid resolution reversed-phase separation coupled with negative-mode sequential mass spectrometry (RRRP-(−)-MS n ); and (3) permethylation derivatization with nanospray sequential mass spectrometry (NSI-MS n ) provides comprehensive glycan structural determination. All methods have limitations; however, a multi-method workflow is an at-line stopgap/solution which mitigates each method's individual shortcoming(s) providing greater opportunity for more comprehensive characterization. This manus c r i p t i s t h e f i r s t t o d e m o n s t r a t e q u a n t i t a t i v e chromatographic separation of the M 5 isomers and the use of a commercially available stable isotope variant of 2-aminobenzoic acid to detect and chromatographically resolve multiple M 5 isomers in bovine ribonuclease B. With this multi-method approach, we have the capabilities to comprehensively characterize a biotherapeutic's glycan array in a de novo manner, including structural isomers at ≥0.1% of the total chromatographic peak area.
Introduction
Significant advancements in methodologies for glycan structural analysis have been achieved in recent years, particularly with respect to chromatography and mass spectrometry Harvey 2005a, b, c; Anumula 2006; AlvarezManilla et al. 2007; Costello et al. 2007; Pabst et al. 2007; Prater et al. 2009) . Even with such advancement, the complex branching patterns and intrinsic isomeric characteristics of glycan structures still pose significant analytical challenges, particularly with respect to the quantitation and characterization of low abundant species.
During the development and commercialization of biotherapeutics, the detection, characterization and justification of minor species is necessary regardless of origin. The detailed characterization of a biotherapeutic's glycan array is a regulatory requirement (ICH 2006; EMEA 2007) ; however, no less important is the characterization of glycan artifacts or modifications spurred during drug processing and/or product characterization (e.g., buffer exchange, enzymatic release, purification, etc.). Consequently, de novo characterization capabilities are needed. Significant effort is made to fully characterize the minor peaks in a chromatographic profile for deeper understanding of the product and the potential impact that a change to product development procedure, particularly changes in manufacturing site or scale, might have on that product. As such, repeated de novo characterization is likely during the lifecycle of a glycosylated biotherapeutic.
Traditional elucidation of glycan structures has involved isolation of individual glycan species by chromatographic separation followed by off-line matrix-assisted laser desorption ionization time-of-flight analysis for basic mass determination and serial exoglycosidase digestions for glycan characterization (Lee 1990; Sutton et al. 1994; Anumula et al. 1998) . Many drawbacks are associated with enzymatic sequencing such as incomplete digestion, variation in enzyme activity, and enzyme purity, specificity and availability, all of which greatly confound analysis and can lead to misinterpretation and/or incomplete understanding of a biotherapeutic's chromatographic profile (Sutton et al. 1994; Harvey et al. 2008) . Separation methods historically have included high pH anion exchange chromatography (HPAEC) (Lee 1990) or normalphase high performance liquid chromatography (NP-HPLC) (Guile et al. 1996) . More recently, separations based upon alternative modes, including reverse-phase (RP-HPLC) and porous graphitic carbon have been implemented (Kopp.K 1997; Delaney et al. 2001; Kawasaki et al. 2003; Ninonuevo et al. 2005; Chen and Flynn 2007; Costello et al. 2007; Pabst et al. 2007; Chen et al. 2009; Prater et al. 2009 ).
In recent years, mass spectrometry-based techniques for glycan structural elucidation have been developed (Reinhold et al. 1995; Viseux et al. 1997; Weiskopf et al. 1997; Brull et al. 1998; Reinhold and Sheeley 1998; Viseux et al. 1998; Weiskopf et al. 1998; Harvey et al. 2002; Pfenninger et al. 2002a; Ashline et al. 2005; Harvey 2005b; Geyer and Geyer 2006) . These methods are analogous to the more established approaches in the proteomics arena, provide exquisite sensitivity, rapid data acquisition and fundamental physical measurement-based analysis and have become an attractive alternative to traditional exoglycosidase sequencing.
A logical extension of glycan analysis is to couple the mass spectrometric analysis with the separation itself. Online liquid chromatography-mass spectrometry (LC-MS) can be a powerful analytical tool for rapid quantitation and identification of glycan species. As noted earlier, HPAEC has long been used to separate glycans into various groups based on charge. With appropriate online desalting, HPAEC can be interfaced with a mass spectrometer creating a method quite advantageous for glycoproteins with highly charged glycan species (Thayer et al. 1998; Bruggink et al. 2005; Chataigne et al. 2008 ). An alternative separation mode, NP-HPLC, uses amide-based columns to separate glycans based on size and hydrophilicity (Guile et al. 1996; Wuhrer et al. 2004 ) and has also been successfully coupled to mass spectrometry (MS) detection (Wuhrer et al. 2004 ). Porous graphitized carbon chromatography is quite compatible with mass spectrometric conditions and demonstrates utility for resolving glycans of similar structure (Kawasaki et al. 2003; Ninonuevo et al. 2005; Costello et al. 2007; Pabst et al. 2007 ). Reverse-phase chromatographic methods demonstrate the capability for resolution of structural isomers as well as segregation by glycan class (Kopp and Werner 1997; Delaney and Vouros 2001; Chen and Flynn 2007; Chen et al. 2009; Prater et al. 2009) and are intrinsically compatible with MS detectors. Recent literature reports have illustrated the implementation of more elaborate MS methodologies such as online MS n schemes (Delaney and Vouros 2001; Chen and Flynn 2007; Chen et al. 2009 ).
In general, upfront separation improves ionization efficiency and helps reduce the complexity of mass spectra; unfortunately, the potential for coelution of discrete glycan species afflicts all chromatographic methods. Coeluting glycomers can be distinguished according to differences in their intact mass; however, the presence of coeluting positional isomers requires additional analysis via subsequent rounds of sequential disassembly.
No single current analytical methodology can independently acquire all the qualitative and quantitative data necessary to completely characterize a glycan topology. For example, positive-mode analysis of reducing-end derivatized protonated glycans is readily compatible with upfront reverse-phase separation. Unfortunately, data quality is compromised by monomer rearrangement and the typical absence of cross-ring fragmentation, limiting structural elucidation to monosaccharide sequencing (Brull et al. 1998; Franz and Lebrilla 2002; Harvey et al. 2002) . Informative cross-ring fragmentation does occur in this mode using metal-adducted ions; however, the presence of "internal residue" fragments stemming from multiple independent cleavages promotes isobaric as well as isomeric product ions making structural determination nebulous (Brull et al. 1998; Franz and Lebrilla 2002; Harvey 2005a Harvey , 2008 Wuhrer et al. 2006) .
Negative-mode analysis of reducing-end derivatized glycans provides more informative structural data than corresponding positive-mode native analysis (Chai et al. 2001 (Chai et al. , 2002 (Chai et al. , 2006 Pfenninger et al. 2002a, b; Harvey 2005b, c, d; Harvey et al. 2008) . Unexpectedly, we report that under rapid resolution reversed-phase chromatography (RRRP) low-energy collisioninduced dissociation (CID) negative-mode conditions, "internal residue" fragment formation is observed similar to positivemode analysis. This greatly complicates spectral interpretation, rendering structural isomer differentiation and de novo characterization difficult.
Orthogonal analysis via permethylation and nanospray sequential mass spectrometry (NSI-MS n ) provides the most informative spectral data for structural elucidation (Ashline et al. , 2007 Alvarez-Manilla et al. 2007; Costello et al. 2007; Prien et al. 2008 Prien et al. , 2009 ). However, permethylated analysis requires an additional derivatization step and is not wellsuited for certain glycan conjugates, such as sulfated glycosaminoglycans (Zaia et al. 2007) .
A simple workflow devised around three well-established core analytical procedures: (1) fluorescence derivatization; (2) online separation coupled with negative-mode sequential mass spectrometry; and (3) permethylation derivatization with NSI-MS n provides a more comprehensive approach toward the characterization of a glycoprotein's glycan array, including minor structural isomers. The use of permethyl derivatization and NSI-MS n is the critical aspect for glycan structural characterization. While the aforementioned mass spectrometric methods have been previously described as stand-alone techniques (Domon and Costello 1988; Reinhold et al. 1995; Weiskopf et al. 1997; Reinhold and Sheeley 1998; Sheeley and Reinhold 1998; Weiskopf et al. 1998; Pfenninger et al. 2002a, b; Ciucanu and Costello 2003; Ashline et al. 2005 Ashline et al. , 2007 Harvey 2005a, b, c, d, e; Kang et al. 2005 Kang et al. , 2008 Lapadula et al. 2005; Anumula 2006; Chen and Flynn 2007; Costello et al. 2007; Harvey et al. 2008; Prien et al. 2008 Prien et al. , 2009 Chen et al. 2009 ), an inclusive workflow coupling these methodologies has not been described, and its demonstration will be of broad utility for the biotherapeutic industry.
Results
The oligosaccharide Man 5 GlcNAc 2 (M 5 ) has been analyzed in detail by a multitude of analytical methodologies providing a forum to draw comparison between the individual analytical methods and perform benefit/shortcoming analysis (Fu et al. 1994; Harvey 2005a, c, d; Costello et al. 2007; Zhuang et al. 2007; Zhao et al. 2008; Prien et al. 2009 ). Here, we demonstrate both quantitation and structural characterization of three M 5 structural topologies present in commercially available M 5 standard derived from porcine thyroglobulin as well as chromatographic separation of multiple M 5 isomers in bovine RNase B.
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Nomenclature
The nomenclature, used herein to identify the intact glycan topologies, is based on the number system for high mannose (Man) isomers as described previously (Prien et al. 2009 ). Briefly, three distinct M 5 topologies were annotated T1, T2 and T3. Additional linear notation is utilized for product ion spectral annotation. We apologize for the introduction of additional notation beyond the established (Domon and Costello 1988) . Our goal for this nomenclature, however, is to afford annotation of product ions without assigning an inferred structure. 
Comprehensive analysis of Man-5 positional isomers
This will help reduce misinterpretation due to the enormous isomeric and isobaric fragment ion overlap intrinsic to MS glycan analysis. A complete description of nomenclature used is discussed in the Materials and methods section. aminobenzoic acid (2-AA) and 2-aminobenzamide (2-AB) labels, respectively) were resolved and quantitated during sample purity assessment using RRRP-(−)-mode MS ( Figure 1A -J). In addition, a single M 6 structure was observed, presumably present due to co-purification during commercial preparation. As evidenced in Table I , the putative M 5 structure composes~96% of the total peak area representing the M 5 pool ( Figure 1A and F, peak (4)), while the three additional M 5 isomers collectively represent~4.0% of the total M 5 peak area ( Figure 1A and F, peaks (1), (3) and (5)). In a previous report, we identified the presence of an early eluting M 5 isomer, which is consistent with the peak (1) retention time relative to peak (4) (Prater et al. 2009 ). Recently, epimerization of the core N-acetylglucosamine (GlcNAc) residue during PNGase F release was reported as a possible origin of certain structural isomers (Liu et al. 2009 ), and our analysis is indicative that the structural differences between peaks (1) and (4) are restricted to linkage or residue identities within the putative oligosaccharide core. A detailed investigation of this structure has recently been completed (to be published). This report, therefore, is focused on the structural elucidation of the remaining three resolved M 5 peaks denoted as peaks (3), (4) and (5) (Figure 1 ).
Released glycans are exposed to harsh reaction conditions during fluorescence derivatization, e.g., heating at 65°C in the presence of acetic acid for 2 h. These conditions might lead to decomposition or structural rearrangement of a glycan's native structure producing low abundant isomers. To address this concern, we performed a study exposing M 5 to the harsh labeling conditions over a time course (2-18 h). If the derivatization conditions lead to isomeric formation, one would expect the peak area for each isomeric species to elevate over time. The study revealed that no changes were observed in the relative peak areas of the T1, T2 and T3 isomeric species, indicating that the labeling conditions do not lead to structural rearrangement (data not shown).
Impact of fluorescence derivatization on separation and mass spectral quality Reducing-end fluorescent derivatization is a widely used methodology (Anumula 2006; Siemiatkoski et al. 2006) . Certain factors must be considered when choosing the appropriate reducing-end label, including label reactivity and compatibility with the desired chromatographic and mass spectrometric methods.
From an examination of the fluorescent profiles ( Figure 1A and F), the most significant difference between the 2-AA and 2-AB labels relates to the shorter separation time provided by the 2-AB label using identical separation conditions. All five peaks 633 Comprehensive analysis of Man-5 positional isomers are observed in both profiles and baseline resolved. However, the advantageous speed of separation provided by the 2-AB label is compromised by the quality of mass spectral data; an obvious difference between the intact mass profiles of 2-AA and 2-AB labeled M 5 is immediately evident (Figure 1B -E and G-J). M 5 -2-AB species tend to ionize as singly charged species and prefer the adduction of acetate (+59 Da). In particular, the adduction of two acetate ions (+118 Da), m/z 1467.5 Figure 1G -J). Conversely, M 5 -2-AA is primarily preserved as deprotonated species [M-H] − , m/z 1354.7 ( Figure 1B -E), resulting in improved spectral quality for the 2-AA labeled substrate.
For our characterization purposes, the 2-AA label confers many advantages over the more commonly used 2-AB label, such as reactivity in aqueous derivatization conditions improving sample workflow efficiency, and an increase in fluorescence intensity improving chromatographic sensitivity for low abundant glycan species (Anumula and Dhume 1998; Anumula 2006) . Intriguingly, 2-AA affords even greater advantage with respect to mass spectrometric analysis. Under negativemode conditions, preferential deprotonation occurs at the carboxyl group of the 2-AA label producing predictable Y-ion fragmentation (Harvey 2005a, c) . As such, this fixed deprotonation promotes efficient MS n disassembly from the nonreducing end to the reducing end of the glycomer allowing sequencing without the burden of structural rearrangement as observed in positive-mode analysis (Brull et al. 1998; Franz and Lebrilla 2002; Chen and Flynn 2007; Harvey et al. 2008 ). In our experience, 2-AB labeled glycan tend to "partially permethylate" (data not shown). In contrast, the 2-AA label appears to readily permethylate and demonstrates a single intact mass species. Having a single intact mass reduces species dilution and spectral profile complexity resulting in improved ion intensity, sensitivity and spectral quality, which is advantageous for de novo characterization of low abundant species. Additionally, 2-AA is available as a 13 [C 6 ] stable isotope analog.
Direct infusion of fluorescent labeled M 5 standard from porcine thyroglobulin Direct infusion of the unseparated 2-AA and 2-AB labeled M 5 standard was executed in negative mode to assess whether the apparent M 5 positional isomers (peaks (1), (3), (4) and (5) in Figure 1A and F) were detectable without separation or further sample processing.
As shown in Figure 2A Figure 2A ). The presence of this ion is inconsistent with the predicted negativemode fragmentation of the T1 M 5 structure and has been previously interpreted as an "internal residue" product ion from the neutral loss of two independent mannose residues (Harvey 2005a) ; however, this ion may also be a Y-ion fragment from additional positional isomers present in the M 5 standard. Adding further to the complexity, a combination of both of the above hypotheses forms an equally valid third explanation. Product ion m/z 485.2 is another low abundant fragment that may be generated from multiple origins: (1) the loss of water (−18) from the C 2α ion, m/z 503.2, of the putative M 5 structure; (2) a D-ion fragment from another isomer that is present; or (3) an isomeric mixture of both (1) and (2) (Supplemental data, Figure S1 ). Similarly, most product ions in the 2-AB labeled M 5 spectrum ( Figure 2B ) are consistent with the canonical M 5 topology, but again two product ions, m/z 485.2 and m/z 1029.3, are inconsistent with the expected. Hence, without separation of the positional isomers and the ability to differentiate native hydroxyls from those formed during fragmentation, definitive assessment of ion origin cannot be made.
An unexpected observation was that under low energy conditions a series of sequential neutral hexose loss (−162 Da) beginning with a 2,4 A cross-ring fragment is observed: (Figure 2A and B). This neutral loss series was previously observed only at higher fragmentation energy levels (Harvey 2005c ). This series exemplifies sequential "internal residue" formation stemming from multiple independent cleavages. As a result, it is plausible that the observed product ions m/z 545.2 and m/z 383.2 may be derived from multiple internal cleavages from different regions of the molecule. Given the information gleaned from the chromatographic separation indicating the presence of multiple M 5 topologies ( Figure 1A and F) as well as the presence of potentially inconsistent ions (m/z 485.2, 1029.3, and 1030.4) and "internal residue" product ion formation in the unseparated (−)-mode MS/MS spectra (Figures 2A and B) , an assessment of localization of these inconsistent ions to a particular chromatographic peak was undertaken. Fig. 4 . NSI-MS n spectra for peak (4) M 5 -2-AA fraction. Sequential disassembly of the putative M 5 structure, T1, prepared as a permethylated 2-AA derivatized sodium adducted species. The MS n pathway followed appears as inserts in the top left corner of the spectra (A-E). Only one of many isomeric partial structures is presented as an associated cartoon. The cartoons are simply used to demonstrate product ion origin specific to the cartoon shown and a single MS n fragmentation pathway unique to the topology shown in (A). Multiple cartoons and MS n fragmentation pathways specific to the intact topology could be shown for each spectrum. To the far right of each spectrum, selected product ions are annotated. Please be advised that not all selected product ions correspond to the associate cartoon; however, the product ions do correspond to the compilation of isomeric precursor ions (e.g., partial structures) that are simultaneously isolated and disassembled. Importantly, all product ions annotated and cartooned originate from the intact species cartooned in (A). Product ions highlighted in bold print were selected for subsequent dissociation and constitute the MS n pathway. Comprehensive analysis of Man-5 positional isomers Online RRRP-(−)-mode MS/MS analysis of M 5 standard from porcine thyroglobulin Both 2-AA and 2-AB derivatized M 5 standards were used during comprehensive analysis; however, only the 2-AA labeled M 5 species, because of the advantages mentioned above, will be subsequently discussed.
Online RRRP-(−)-mode MS/MS: peak (4),~96% abundance Online LC-MS analysis of peak (4) revealed a parent ion of m/z 1354.7 for the 2-AA labeled M 5 ( Figure 3A ). The observation of diagnostic ions m/z 647.3, m/z 629.3, m/z 575.3 and m/z 503.3 confirm the presence of three mannose residues on the 6-antenna and is indicative of the T1 branching pattern ( Figure 3A) . Interestingly, the inconsistent product ion m/z 1030.4 and the sequential neutral loss series beginning with the 2,4 A cross-ring fragment ion m/z 869.2 are observed in the peak (4) MS/MS spectrum. Equally important is the absence of the m/z 485.2 product ion. These findings suggest that m/z 1030.4 represents the loss of two independent mannose residues consistent with previous hypotheses (Harvey 2005a) , while the sequential neutral loss series indicates that Comprehensive analysis of Man-5 positional isomers "internal residue" formation occurs similar to the positive mode.
Online RRRP-(−)-mode MS/MS: peak (3),~0.7% abundance The "D-ion" is a diagnostic of gross structural features such as 6-antennal branching (Harvey 2005c) . Specifically, the formation of this ion originates from neutral loss of the 3-antenna and loss of the penultimate and reducing-end GlcNAc-GlcNAc di-N-Acetyl-D-glucoaminosyl moiety. The "D-ion" generates prevalent product ions corresponding to the loss of water (D′) and subsequent 0,3 A-ion and C-ion, (C/Z −18 Da), (C/Z −72 Da) and (C/Z −144 Da), respectively. These diagnostic ions are observed in the MS/MS spectrum for peak (3) (Figure 3B ), albeit with one less mannose residue than observed for the T1 topology of peak (4) ( Figure 3A) . As shown in Figure 3B 0,3 A 2 -ion) correspond to two mannose residues present on the 6-antenna suggesting gross antennary structural differences between the M 5 species present in peaks (3) and (4). Moreover, ions representative of the three mannose residues concomitant with the T1 6-antennae (i.e., m/z 647.3, 629.3, and 575.3) are notably absent ( Figure 3B ). As such, the presence and increased relative abundance of m/z 1030.4 may be rationalized in an entirely different manner. Here, the product ion is unlikely to be an "internal residue" fragment ion but the product ion of a single cleavage event occurring between a terminal di-mannosyl group (−341 Da; H 3 N 1 n-2AA- [OH] ; Y 3α or Y 3β ) and the β1,4 core mannose of the proposed T2 structure ( Figure 3B ).
Online RRRP-(−)-mode MS/MS: peak (5),~0.1% abundance A low abundant peak, peak (5) in Figure 1A and E, occupying 0.1% of the total M 5 fluorescent peak area presents a parent ion (m/z 1354.7) and MS/MS product ions that are similar, but not identical, to the other M 5 structures ( Figure 3C ). Notably, this species also contains the m/z 1030.4 ion. Unfortunately, the online MS/MS spectral quality is insufficient to confidently propose a structure ( Figure 3C ).
In summary, the sensitivity and resolving power of online RRRP-(−)-mode MS/MS and MS n (Supplemental data, Figure  S2 ) provides conclusive evidence confirming the presence of multiple M 5 structures. Unfortunately, the potential formation of "internal residue" fragments can lead to data ambiguity and confound structural characterization without having a priori knowledge of the structures that are present. That is, while the M 5 isomers may be separated chromatographically, online negative-mode analysis cannot unambiguously differentiate and characterize the structural differences of the M 5 species in a de novo manner, thereby requiring alternative analytic tools for structural annotation. Fortunately, as detailed in the subsequent sections, infusion-based MS n of permethylated glycans provides the specific information necessary to assign structural motifs.
In order to reconcile the specific structural identities of each peak in the fluorescent profile, peaks (3), (4) and (5) were isolated from the chromatographic separation, subjected to permethylation and subsequently characterized by NSI-MS n analysis.
Permethylated NSI-MS n analysis
Permethylated NSI-MS n has been discussed in detail in the literature (Reinhold et al. 1995; Viseux et al. 1997; Weiskopf et al. 1997 Weiskopf et al. , 1998 Reinhold and Sheeley 1998; Sheeley and Reinhold 1998; Viseux et al. 1998; Karlsson, Schulz, et al. 2004; Karlsson, Wilson, et al. 2004; Ashline et al. 2005 Ashline et al. , 2007 Lapadula et al. 2005; Hanneman et al. 2006; Costello et al. 2007; Prien et al. 2008 Prien et al. , 2009 ). In short, several critical benefits of glycan permethylation with respect to structural characterization and mass spectrometric analysis include: (1) increased oligosaccharide ionization efficiency (Harvey 1999) ; (2) increased abundance of diagnostic cross-ring fragments which can be utilized to determine linkage position (Mechref et al. 2003 , Morelle et al. 2004 Ashline et al. 2005) ; and (3) upon fragmentation, terminal and internal residues exhibit mass differences (14 Da) depending on the number of exposed hydroxyl groups, commonly known as "scars" (Ashline et al. 2007; Costello et al. 2007 ). These attributes allow for the de novo characterization of individual structures from unseparated glycan pools (Reinhold et al. 1995; Viseux et al. 1997 Viseux et al. , 1998 Weiskopf et al. 1997 Weiskopf et al. , 1998 Reinhold and Sheeley 1998; Sheeley and Reinhold 1998; Karlsson, Schulz, et al. 2004; Karlsson, Wilson, et al. 2004; Ashline et al. 2005 Ashline et al. , 2007 Lapadula et al. 2005; Hanneman et al. 2006; Costello et al. 2007; Prien et al. 2008 Prien et al. , 2009 ).
Permethylated NSI-MS n analysis of M 5 positional isomers
Structural rearrangement and isomeric formation consequent of chemical modification and gas-phase analysis is a persistent concern surrounding permethyl derivatization and ion trap disassembly. Here, these hypotheses are nullified knowing the discrete M 5 isomers are separated by chromatography prior to permethyl derivatization and mass spectrometric conditions.
Permethylated NSI-MS n : peak (4)
The signature MS n pathway, m/z 1728. . NSI-MS n spectra for peak (3) M 5 -2-AA collected fraction. Sequential disassembly of the T2 M 5 positional isomer, prepared as a permethylated 2-AA derivatized sodium adducted species. The MS n pathway followed appears as inserts in the top left corner of the spectra (A-E). Only one of many isomeric partial structures is presented as an associated cartoon. The cartoons are simply used to demonstrate product ion origin specific to the cartoon shown and a single MS n fragmentation pathway unique to the topology shown in (A). Multiple cartoons and MS n fragmentation pathways specific to the intact topology could be shown for each spectrum. To the far right of each spectrum, selected product ions are annotated. Please be advised that not all selected product ions correspond to the associate cartoon; however, the product ions do correspond to the compilation of isomeric precursor ions (e.g., partial structures) that are simultaneously isolated and disassembled. Importantly, all product ions annotated and cartooned originate from the intact species cartooned in (A). Product ions highlighted in bold print were selected for subsequent dissociation and constitute the MS n pathway. Comprehensive analysis of Man-5 positional isomers or H 1 N 1 -[ene 1 OH 2 ]), used to distinguish and characterize the putative M 5 structure from an unseparated glycan pool (Prien et al. 2009 ), was identified and followed in the separated peak (4) fraction confirming this peak as the putative T1 M 5 structure (Figure 4 and Table II , pathway d) (Supplemental data, Figure S3 ). Importantly, by chromatographically isolating the M 5 isomers prior to permethylated NSI-MS n characterization, the ions inconsistent with the T1 structure previously observed in the unseparated pool, m/z 880.4 (H 3 N 1 -[ (Figure 4 ) (Supplemental data, Figure S3 ). The presence of a terminal B 2 -ion and C 2 -ion stemming from the m/z 880.4 precursor indicates that the single exposed hydroxyl group is located on the β1,4 Man-GlcNAc core and confirms that peak (3) demonstrates the T2 topology ( Figure 5 and Table  II , pathways r-s).
Antennal sequencing and linkage determination can be performed by following specific MS n fragment ion pathways that include appropriate cross-ring fragments. For example, the terminal mannosyl residue on the 6-antenna of the T2 structure was confirmed as 1→3 linked through observation of MS 7 product ion m/z 343.3 ion following the MS n fragmentation pathway: m/ z 1728. Permethylated NSI-MS n : peak (5) A major advantage of nanospray and direct infusion is the exquisite sensitivity and the ability to signal average over extended infusion times. These attributes allow for the acquisition of high quality spectral data even for a low abundant species, such as the structure eluting at peak (5) (Figure 6 ). The MS n pathways followed to elucidate the peaks (3) and (5) (3) and (5) are composed of the same composition and "scar" count, H 3 N 1 -[ene 1 OH 1 ], the m/z 880.4 product ion for peak (5) represents a different compilation of structures compared to the peak (3) T2 pathway ( Figure 5D ). In the peak (5) pathway, product ion m/z 676.3 of the MS 5 m/z 880.4 spectra is consistent with a B/Y-ion having a H 2 N 1 composition with a single exposed hydroxyl group "scar" ( Figure 6D ). Additionally, the presence of a fully permethylated terminal C 1 -ion, m/z 259.1, in the MS 6 m/z 676.3 spectrum indicates that the single exposed hydroxyl group is located on the β1,4 Man-GlcNAc core, confirming peak (5) as having a unique structure, termed T3 ( Figure 6E ). Product ion m/z 676.3 is absent in the MS 5 m/z 880.4 spectrum from the T2 structure ( Figure 5D ). Therefore, product ion m/z 676.3 from an MS 5 m/z 880.4 precursor ion is diagnostic to structure T3 (Table II, 
pathway t-v).
Outer-arm linkage analysis was attempted on the isolated T3 structure. While permethylated MS n data obviated the terminal 6-antennal disaccharide linkage as a 1→4 or 1→6 linkage, conclusive confirmation of the linkage as a 1→2, 1→3 or a combination of the two was unattainable (data not shown). Negative-mode MS n was also attempted on the isolated T3 species; however, spectra quality was insufficient (data not shown). Although not definitively characterized at this time, the data suggest the linkage between the terminal hex-hex disaccharide of the 6-antennae is most likely a 1→2, 1→3 or a mixture of both.
The spectral set for T3 highlights many important principles to consider when interpreting data sets generated during permethylated NSI-MS n experimentation. For instance, the MS 4 spectrum, m/z 1084.4, of Figure 6C represents a compilation of multiple isomeric fragment ions that were isolated and subsequently fragmented from the m/z 1302.6 precursor ion. As shown in Figure 6B , two fragment ions stemming from different regions of the precursor ion are composed of H 4 N 1 -[ene 1 OH 1 ], m/z 1084.4. Consequently, the subsequent MS 4 m/z 1084.4 product ion spectrum consists Fig. 6 . NSI-MS n spectra for peak (5) M 5 -2-AA collected fraction. Sequential disassembly of the T2 M 5 positional isomer, prepared as a permethylated 2-AA derivatized sodium adducted species. The MS n pathway followed appears as inserts in the top left corner of the spectra (A-E). Only one of many isomeric partial structures is presented as an associated cartoon. The cartoons are simply used to demonstrate product ion origin specific to the cartoon shown and a single MS n fragmentation pathway unique to the topology shown in (A). Multiple cartoons and MS n fragmentation pathways specific to the intact topology could be shown for each spectrum. To the far right of each spectrum, selected product ions are annotated. Please be advised that not all selected product ions correspond to the associate cartoon; however, the product ions do correspond to the compilation of isomeric precursor ions (e.g., partial structures) that are simultaneously isolated and disassembled. Importantly, all product ions annotated and cartooned originate from the intact species cartooned in (A). Product ions highlighted in bold print were selected for subsequent dissociation and constitute the MS n pathway. Comprehensive analysis of Man-5 positional isomers of isomeric, isobaric and "non-isobaric" fragment ions that may be unique to one, some or all the isomeric parent ions ( Figure 8C ). For example, the base peak, m/z 866.3, is the product of an m/z 1084.4 fragment ion originating from a cleavage event occurring between the two terminal mannose residues of the 6-antennae (Supplemental data, Figure S5 ). Meanwhile, m/z 709.4 (H 3 -[ 0,4 A]) and m/z 737.3 (H 3 -[ 3,5 A]) represent cross-ring product ions arising from a different m/z 1084.4 parent ion having been previously cleaved between the single 3-antennae mannose and the core β1,4 linked mannose residues (Supplemental data, Figure S5 ). Hence, multiple isomeric fragments are present at each stage along an MS n spectra set, and only by following specific productprecursor fragment ion pathways within that spectral set may a glycan structure be elucidated (Table II) . This report as well as others (Ashline et al. , 2007 Hanneman et al. 2006; Prien et al. 2008 Prien et al. , 2009 Bleckmann et al. 2009 ) demonstrates that permethylated NSI-MS n shows utility for de novo glycan characterization and the ability to differentiate structural isomers.
12 [C 6 ]AA and 13 [C 6 ]AA stable isotope fluorescence derivatization of M 5 and RNase B An immediate concern surrounding the use of a purchased standard for analysis is whether the low abundant M 5 isomers are of biologic origin or artifacts of the purification process. As noted above, 2-AA is readily available as a 13 [C 6 ] stable isotopic variant. Figure 7 depicts a RRRP chromatogram of three 2-AA derivatized glycan samples: (1) 2-12 [C 6 ]AA labeled glycans derived from RNase B highlighted in black; (2) 2-13 [C 6 ]AA labeled M 5 standard derived from porcine thyroglobulin highlighted in red; and (3) a sample mixture of 2-12 [C 6 ]AA labeled glycans from RNase B "spiked" with 7.4 pmol of 2-13 [C 6 ]AA labeled M 5 standard from porcine thyroglobulin highlighted in green. Importantly, 2-AA stable isotope analogs co-elute during reverse-phase chromatography, demonstrating no peak dispersion or chromatographic variance as shown in Figure 7 . A mass difference of 6 Da between the isotopic pair provides sufficient m/z value dispersion so that each isotopically labeled species may be distinguished and quantified without reciprocal analog interference. Additionally, ion efficiency issues are mitigated due to internal isotopic labeled references which ionize identical to their non-isotopic labeled glycan counterpart. A more in-depth discussion of applications using the 2-13 [C 6 ]AA variant will be presented in a subsequent publication. As Figure 7 illustrates, all three samples contain peaks (1a), (5b), (6) and (7a), representing the various species of M 5 . These findings confirm that multiple M 5 isomers exist in RNase B. Figure 8A -E demonstrates negative-mode MS profiles of various RRRP elution peaks of the 12 [C 6 ]AA labeled RNase B released glycan sample. The presence of m/z 1354.6 in the MS profile of peaks (1a), (5b) and (7a) may be interpreted in multiple ways: (1) the neutral loss from in-source fragmentation of three (−484 Da), two (−324 Da) and one (−162 Da) mannose residues from the known presence of 12 [C 6 ]AA labeled M 8 , M 7 , and M 6 glycans, respectively ( Figure 8B-D) ; (2) Comprehensive analysis of Man-5 positional isomers higher-order oligomannose species; and (3) a combination of both in-source fragmentation and the presence of coeluting species. Subsequent analysis is required to conclusively determine the origin of m/z 1354.6 ion. As a consequence of in-source fragmentation, extracted ion chromatograms of native species should be used cautiously as a diagnostic tool for monitoring and quantifying glycans. Figure 8F -J represents the MS profiles of peaks (1a), (3), (5b), (6) and (7a) of the blended RNase B and M 5 isotopically labeled sample. The expected parent ion of the 13 [C 6 ]AA labeled M 5 standard has a mass offset of +6 Da, i.e., m/z 1360.6. As the spectra demonstrate ( Figure 8G-I Figure 8J represents the D2 M 7 isomer (identified through permethylated MS n disassembly, data not shown). In this instance, m/z 1354.6 and m/z 1360.6 are absent, suggesting that in-source fragmentation did not occur, thereby providing greater evidence for the presence of multiple M 5 isomers eluting at various points in the chromatogram.
To determine the origin of the m/z 1354.6 ion in RNase B, all fractions containing this ion (peaks (1a), (5b), (6) and (7)) were collected and subjected to permethylation. Permethyl derivatization "caps" the indigenous intact glycan structures, allowing differentiation from in-source fragment contaminants of higher order oligomannose glycans by a +14 Da shift. The permethylated NSI-MS n results from the RNase B-collected fractions demonstrate the presence of distinct M 5 species at each elution point (peaks (1a), (5b), (6) and (7)) (NSI-MS n spectra and fragmentation pathways were similar to those described for the M 5 standard, data not shown). Two conclusions can be drawn from the stable isotope and permethylated NSI-MS n experimentation results: (1) multiple M 5 isomers exist in bovine RNase B confirming a previous report (Prien et al. 2009); and (2) , the low abundant isomers of the purchased M 5 standard derived from porcine thyroglobulin are not artifacts of the commercial purification process.
Discussion
The mission of this manuscript is to share our multi-method approach toward de novo glycan characterization and quantitation, including minor species at or below~0.1%, consistent with regulatory expectations. The M 5 isomer species are in low abundance (0.7% and 0.1% of the total) and exemplary to demonstrate our solution toward the characterization of minor species. A simple workflow devised around three core well-established analytical procedures: (1) fluorescence derivatization; (2) online rapid resolution reversed-phase separation coupled with negative-mode sequential mass spectrometry (RRRP-(−)-MS n ); and (3) permethylation derivatization with NSI-MS n analysis provides comprehensive glycomer and minor structural isomer coverage. For the most comprehensive glycan coverage, an initial permethylated NSI-MS n pre-screening step is required providing upfront identification and de novo characterization of the species present in the entire glycan pool. The use of permethylated NSI-MS n is the critical aspect for glycan structural characterization both for initial direct infusion pre-screening step and chromatographically separated fractions. The excellent resolution and high sensitivity of RRRP-(−)-mode MS n may then be utilized to rapidly track down, confirm and quantitate individual separated glycan structures. Coeluting glycans and unresolved positional isomers are then distinguished through a subsequent round of permethylation derivatization and NSI-MS n on the isolated fractions. The end result is an extensive highly sensitive glycan map or library, depicting well-characterized structures assigned to a particular retention time. Once retention times are associated with specific glycan structures (including structural isomers), RRRP mapping may be used for routine analysis, and glycan structures may be assigned. Here, this feasiblity study demonstrates that both qualitative and quantitative data are obtained for low abundant species using this multi-method workflow. With this approach, we have the potential to perform de novo glycan characterization of biotherapeutics, including low abundant species exceeding regulatory expectations. The application of this methodology to monoclonal antibodies will be the focus of forthcoming articles.
Materials and methods

Materials
Oligomannose-5 (M 5 ) standard from porcine thyroglobulin was purchased from Prozyme (San Leandro, CA). 2-AA and 2-AB labeling kits consisting of dimethyl sulfoxide (DMSO), glacial acetic acid (HOAc), the fluorescent reagent and sodium cyanoborohydride (NaCNBH 3 ) were purchased from QA-Bio (Palm Desert, CA). Sodium hydroxide beads (small), proteomics-grade bovine ribonuclease B (RNase B), 12 [C 6 ]-aminobenzoic acid and 13 [C 6 ]-aminobenzoic acid were purchased from Sigma-Aldrich (St. Louis, MO). Normalphase tips (DPS-6S resin, 10 μL bed volume) were sourced from PhyNexus Inc (San Jose, CA). Macro SpinColumns™ were obtained from Harvard Apparatus (Holliston, MA). PNGase F was purchased from New England Biolabs (Ipswich, MA).
Enzymatic release and purification of RNase B N-glycans N-linked glycans from 1 mg of bovine RNase B were released enzymatically following directions from the supplier. Protein and detergents were removed by a C 18 Sep-Pak, and the flow-through fraction was desalted on porous graphitized carbon as described previously (Hanneman et al. 2006) . Purified glycans were dried by vacuum centrifugation.
Fluorescent labeling
A 50-mg/mL solution of 2-AB or 2-AA labeling reagent was prepared by dissolution of the solid reagent in a DMSOHOAc solution (70% DMSO/30% HOAc, v/v). The solution was used to stabilize a 6-mg quantity of NaCNBH 3 . M 5 standard (10 μg) was resuspended in 7 μL of 2-AA or 2-AB labeling solution and then incubated for 2 h at 65°C. Sample cleanup with normal-phase PhyTips Excess reducing-end label was removed from the reaction mixture using normal-phase DPA-6S PhyTips as described previously (Prater et al. 2007 ). Briefly, PhyTips were prerinsed with 20% acetonitrile (ACN) and reequilibrated with 96% ACN prior to loading of the diluted glycans. The excess label was removed by washing the loaded PhyTips four times with 96% ACN and the glycans eluted with 20% ACN. Samples were dried by vacuum centrifugation and resuspended in 1 mL of HPLC-grade water. Comparative sample mixtures of 12 [C 6 ]AA labeled M 5 standard and 13 [C 6 ]-AA labeled RNase B-released glycans were combined during the normal-phase DPA-6S PhyTip cleanup stage.
Rapid resolution reverse-phase HPLC M 5 isomers were separated on an Agilent Zorbex Rapid Resolution SB-C18 column (2.1 × 50 mm, 1.8 μm) connected to an Agilent 1100 HPLC equipped with online fluorescence detection. The excitation and emission wavelength parameters were 360 nm/425 nm and 330 nm/420 nm for the 2-AA and 2-AB, respectively. The mobile phases used were as follows: (A) 0.1% HOAc; (B) 5% ACN, 0.1% HOAc; and (C) 80% ACN, 0.1% HOAc. The system was operated at a constant flow rate of 333 μL/min and a temperature of 50°C. Following injection, reagents were eluted with a 2-min isocratic elution at 30% mobile phase B. This was followed by an initial gradient step of increasing mobile phase B at 0.55%/min over 40 min for 2-AA labeled glycans and at 0.55%/min over 20 min for 2-AB labeled species and then a second gradient step of increasing mobile phase B of 1.43%/min over 7 min. Finally, the column was regenerated with 100% mobile phase C for 4 min and reequilibrated at initial condition for an additional 4 min prior to subsequent injection.
Online electrospray ionization-MS and negative-mode MS n detection The outlet of the chromatographic separation was coupled directly to a linear ion trap mass spectrometer (Thermo LTQ XL, San Jose, CA) equipped with an electrospray ionization source. The instrument was tuned for either 2-AA or 2-AB labeled samples by infusion of a 1-pmol/μL solution of the corresponding labeled oligomannose-5 standard in mobile phase A. The tuning solutions were infused at 30 μL/min into a 30% mobile phase B background flow of 300 μL/min. The capillary temperature was set at 250°C, and the spray voltage was −2.5 kV. For tandem MS/MS, parent ions were selected with an isolation window width of 5 m/z, the normalized collision energy was set at 35%, and the activation was conducted at Q = 0.25 for 50 ms. For subsequent MS n stages, isolation width window was set at 2 m/z, the CID set at 35% with an activation Q = 0.25 for 50 ms.
Solid-phase spin-column permethylation Glycans were permethylated according to a previously reported method (Kang et al. 2008) , however slightly optimized for 2-AA and 2-AB derivatized species. Briefly, samples were resuspended in 60% DMSO, 37.2% iodomethane and 2.8% water. To reduce partial permethylation, 15 sample recycles, opposed to eight sample recycles for underivatized glycans, were employed.
Nanospray sequential mass spectrometry Sequential mass spectra were obtained from linear ion trap mass spectrometer (Thermo LTQ XL) equipped with a TriVersa Nanomate™-automated nanospray ion source (Advion, Ithaca, NY). Signal averaging was accomplished through adjusting the number of scans relative to the ion signal strength. Isolation window width varied dependent upon potential interference from noninformative "isobar-like" fragments, averaging 0.5 m/z. Although a narrow isolation window width allows fewer ions to enter the trap, signal averaging over extended infusion time results in significantly improved signal. Collision parameters were left at default values with normalized collision energy set to 35% or optimized to values leaving a minimal parent ion peak. Activation Q was set at 0.25 and activation time for 30 ms.
Data analysis
Data sets generated from MS n experiments possess an enormous wealth of data, and interpretation can be quite cumbersome. To help alleviate interpretation burden and validate structural assignments, the MS n spectra were given as inputs to gtSuite™ glycoanalytic software (Glycome Technologies Inc., Portsmouth, NH), which provided spectral annotation and structural isomer identification as outputs. Negative-mode MS/MS and MS n data were interpreted manually.
Nomenclature
Class names have been established to represent monomers with identical mass: H for hexose (mannose, glucose, galactose); F for deoxyhexose (fucose); N for HexNAc (GlcNAc and GalNAc); and S for sialic acid, NeuAc. Reducing-end monomers are denoted in the lower case h, n, f, etc. For example, H 4 N 2 n represents a composition of four hexoses, two internal HexNAcs and a reducing-end HexNAc. When subjected to dissociation, permethylated glycans produce distinguishable hydroxyl group (-OH) and pyranosylene (-ene) "scars" where glycosidic bond cleavage has occurred . Product ions are assigned a residue count paired with scars, which are denoted by (OH) and (ene), each of which may be modified by a count. For example, H 3 -[ene 1 OH 2 ] represents a hexose trimer with both one (ene) and two (OH) "scars". Native glycans when subjected to dissociation produce indistinguishable hydroxyl group (-OH) "scars" where glycosidic bond cleavage has occurred. As used herein, native product ions will be assigned a residue count paired with scars denoted by (OH) and (ene). (OH) scars will not be followed by a count subscript because of the inability to discriminate between fragments caused by a single cleavage event or multiple cleavage events. For example, H 3 -[eneOH] represents three hexose monomers with one (ene) and one (OH).
A popular structurally descriptive nomenclature has been established by Domon and Costello (1988) . This nomenclature is most suitably used once a structure can be confidently assigned to a product ion. Briefly, Domon and Costello nomenclature defines particular fragments as being of type A, B, C, X, Y or Z. Ion types B/Y and C/Z are complementary fragments resultant from cleavage around the glycosidic oxygen. B-type ions indicate an (ene) cleavage at the fragments reducing end, C-type ions indicate an (OH) at the reducing end, Y-type ions indicate an (OH) at the nonreducing end and Z-type ions indicate an (ene) at the nonreducing end. For example, B/Y/Y notation represents a fragment with one (ene) cleavage at the reducing end and two (OH) cleavages at the nonreducing end. The terms (ene) and (OH) do not imply location of the scars; Domon and Costello nomenclature is required for that. As such, the (ene)/(OH) notation is more appropriate for product ion annotation, and the B/C/Y/Z notation is more appropriate once a structure can be confidently assigned to a product ion.
In this manuscript, we employ Domon and Costello nomenclature for cross-ring fragmentation; however, residue count is denoted as H, N, F, etc, instead of subscript (Domon and Costello 1988) . Examples are as follows: (1) of an open hydroxyl "scar" on the fragment ion. While the proposed nomenclature provides appropriate identification without inference to specific structures, the product ions of cross-ring fragmentation are still not appropriately described. Therefore, in this manuscript, when appropriate or when description necessitates, both Domon and Costello and the above newly proposed nomenclature will be used to identify product ions.
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Abbreviations 2-AA 2-aminobenzoic acid; 2-AB 2-aminobenzamide; ACN acetonitrile; CID collision-induced dissociation; DMSO dimethyl sulfoxide; GlcNAc N-acetylglucosamine; H hexose; HOAc glacial acetic acid; HPAEC high pH anion exchange chromatography; LC-MS liquid chromatography-mass spectrometry; M 5 Man 5 GlcNAc 2 ; Man mannose; MS mass spectrometry; MS/MS tandem mass spectrometry; MS n sequential mass spectrometry; N N-acetylhexosamine; n reducing-end N-acetylhexosamine; NP-HPLC normal-phase high performance liquid chromatography; NSI nanospray ionization; NSI-MS n nanospray sequential mass spectrometry; RP-HPLC reverse-phase high performance liquid chromatography; RRRP rapid resolution reversed-phase chromatography.
